Downregulating forkhead box M1 inhibits proliferation by inhibiting autophagy in the sw480 cell line

Shibiao Zhong1, Aiyan Zhou2, Fanghua Qi2

  • 1Department of Anorectal Surgery, Minzu Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi Zhuang Autonomous Region 530001, P.R. China.

Biomedical Reports
|July 8, 2017
PubMed

Insights

Forkhead Box M1 (FoxM1) oncogene knockdown inhibits colon cancer cell proliferation. This study reveals FoxM1 regulates cancer cell growth by affecting autophagy, a key cellular process.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cellular Biology

Background:

  • Forkhead Box M1 (FoxM1) is a key oncogene implicated in various cancers, including colon cancer.
  • Overexpression of FoxM1 is frequently observed in malignant tumors, suggesting its critical role in cancer development and progression.

Purpose of the Study:

  • To elucidate the mechanism by which FoxM1 influences cancer cell proliferation through the regulation of autophagy.
  • To investigate the impact of FoxM1 downregulation on autophagy and cell proliferation in the sw480 colon cancer cell line.

Main Methods:

  • Short hairpin RNA (shRNA) was utilized to knock down FoxM1 expression in sw480 cells.
  • Autophagy levels were assessed by measuring the expression of autophagy markers LC3 and P62.
  • Cell proliferation was evaluated in FoxM1-downregulated cells.

Main Results:

  • Downregulation of FoxM1 led to a significant inhibition of autophagy in sw480 cells compared to control groups.
  • Further analysis indicated that reduced FoxM1 levels mimic the effects of known autophagy inhibitors.
  • Inhibition of FoxM1 expression resulted in decreased cell proliferation within the sw480 colon cancer cell line.

Conclusions:

  • FoxM1 plays a crucial role in promoting colon cancer cell proliferation, partly through the modulation of autophagy.
  • Targeting FoxM1 could represent a potential therapeutic strategy for colon cancer by disrupting both cell proliferation and autophagy pathways.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.8K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.7K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.7K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.9K